These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 3006888)

  • 1. Omeprazole, a specific inhibitor of H+-K+-ATPase, inhibits bone resorption in vitro.
    Tuukkanen J; Väänänen HK
    Calcif Tissue Int; 1986 Feb; 38(2):123-5. PubMed ID: 3006888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Inhibition of H+/K+-ATPase in the parietal cell with omeprazole: a new principle of gastric acid inhibition].
    Lamers CB
    Ned Tijdschr Geneeskd; 1985 Apr; 129(15):679-82. PubMed ID: 2986019
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of gastric K+/H+-ATPase by acid-activated 2-((2-pyridylmethyl)sulphinyl)benzimidazole products.
    Beil W; Hannemann H; Mädge S; Sewing KF
    Eur J Pharmacol; 1987 Jan; 133(1):37-45. PubMed ID: 3030771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for acid-induced transformation of omeprazole into an active inhibitor of (H+ + K+)-ATPase within the parietal cell.
    Wallmark B; Brändström A; Larsson H
    Biochim Biophys Acta; 1984 Dec; 778(3):549-58. PubMed ID: 6095911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Na+/H+ antiporter is the primary proton transport system used by osteoclasts during bone resorption.
    Hall TJ; Chambers TJ
    J Cell Physiol; 1990 Feb; 142(2):420-4. PubMed ID: 2154508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Discovery and development of the proton pump inhibitor].
    Igata H; Okabe S
    Nihon Rinsho; 1992 Jan; 50(1):11-7. PubMed ID: 1311779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The mechanism of action of the gastric acid secretion inhibitor omeprazole.
    Lindberg P; Nordberg P; Alminger T; Brändström A; Wallmark B
    J Med Chem; 1986 Aug; 29(8):1327-9. PubMed ID: 3016260
    [No Abstract]   [Full Text] [Related]  

  • 8. Mechanism of action of omeprazole.
    Wallmark B
    Scand J Gastroenterol Suppl; 1986; 118():11-7. PubMed ID: 3014640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of gastric (H+ + K+)-ATPase by the substituted benzimidazole, picoprazole.
    Wallmark B; Sachs G; Mardh S; Fellenius E
    Biochim Biophys Acta; 1983 Feb; 728(1):31-8. PubMed ID: 6299338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Omeprazole, a specific inhibitor of gastric (H+-K+)-ATPase, is a H+-activated oxidizing agent of sulfhydryl groups.
    Im WB; Sih JC; Blakeman DP; McGrath JP
    J Biol Chem; 1985 Apr; 260(8):4591-7. PubMed ID: 2985559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substituted benzimidazoles inhibit gastric acid secretion by blocking (H+ + K+)ATPase.
    Fellenius E; Berglindh T; Sachs G; Olbe L; Elander B; Sjöstrand SE; Wallmark B
    Nature; 1981 Mar; 290(5802):159-61. PubMed ID: 6259537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between gastric acid secretion and gastric H+,K+-ATPase activity.
    Wallmark B; Larsson H; Humble L
    J Biol Chem; 1985 Nov; 260(25):13681-4. PubMed ID: 2997178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of H+,K+-ATPase by methyl(E)-2-(3,4-dimethoxystyryl)-benzimidazole-4-carboxylate (ALE-36).
    Yamamoto O; Tanaka H; Ueda F; Kimura K
    Scand J Gastroenterol Suppl; 1989; 162():178-81. PubMed ID: 2556788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mechanism for inhibition of gastric (H+ + K+)-ATPase by omeprazole.
    Lorentzon P; Eklundh B; Brändström A; Wallmark B
    Biochim Biophys Acta; 1985 Jul; 817(1):25-32. PubMed ID: 2988621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on the mechanism of action of omeprazole.
    Keeling DJ; Fallowfield C; Milliner KJ; Tingley SK; Ife RJ; Underwood AH
    Biochem Pharmacol; 1985 Aug; 34(16):2967-73. PubMed ID: 2992525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of omeprazole on gastric secretion in H+,K+-ATPase and in pepsinogen-rich cell fractions from rabbit gastric mucosa.
    Fryklund J; Wallmark B; Larsson H; Helander HF
    Biochem Pharmacol; 1984 Jan; 33(2):273-80. PubMed ID: 6322797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Omeprazole: mode of action and effect on acid secretion in animals.
    Wallmark B
    Scand J Gastroenterol Suppl; 1989; 166():12-8. PubMed ID: 2557668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Irreversible inactivation of rat gastric (H+-K+)-ATPase in vivo by omeprazole.
    Im WB; Blakeman DP; Davis JP
    Biochem Biophys Res Commun; 1985 Jan; 126(1):78-82. PubMed ID: 2982382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of partially purified K+/H+-ATPase from guinea-pig isolated and enriched parietal cells by substituted benzimidazoles.
    Beil W; Sewing KF
    Br J Pharmacol; 1984 Jul; 82(3):651-7. PubMed ID: 6146367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. By 1023/SK&F 96022: biochemistry of a novel (H+ + K+)-ATPase inhibitor.
    Simon WA; Keeling DJ; Laing SM; Fallowfield C; Taylor AG
    Biochem Pharmacol; 1990 Jun; 39(11):1799-806. PubMed ID: 2160820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.